The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
NIOSH has released an updated list of hazardous drugs for healthcare workers, incorporating 25 new drugs and removing seven.
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...
Neither drug is considered as effective as the brand ... requiring treatment for type 2 diabetes," Cody Stanford said. The list price for Ozempic and Mounjaro each run more than $1,000 a month ...